Altria Group, Inc. NYSE: MO papierosy, wyroby tytoniowe

[slayer74]

Altria group earnings
Release Date
Jan 30, 2020
Period End
Q4 12/2019
EPS / Forecast
1.02 / 1.02
Revenue / Forecast
4.80B / 4.88B

https://www.investing.com/equities/altr ... p-earnings

[slayer74]

3 Reasons To Buy Altria

Summary
Selling in Altria stock is accelerating again.

Dividend yield covered well.

Acceleration in e-vapor business growing.
...
https://seekingalpha.com/article/432141 ... ent=link-0

[slayer74]

Does Altria Stock Offer More Than a Pretty Dividend?
https://247wallst.com/consumer-products ... -dividend/

[slayer74]

How Will Altria Stock Stand Up to COVID-19?
https://247wallst.com/consumer-products ... -covid-19/
---
WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Wednesday that it had filed a complaint aimed at forcing Altria Group (N:MO) to sell its $12.8 billion investment in e-cigarette maker JUUL.
https://www.investing.com/news/stock-ma ... ul-2128411

[slayer74]

EPS / Forecast
1.09 / 0.99

Revenue / Forecast
5.05B / 4.62B

[slayer74]

Altria Stock's Attractive Value Proposition Going Into Earnings

https://247wallst.com/consumer-products ... -earnings/

[slayer74]

How Juul Setbacks Will Likely Impact Altria Stock?

Altria Group Inc. (NYSE: MO) investors will want to note the latest setbacks for Juul Labs Inc., the e-cigarette manufacturer.

This week, Juul said it’s cutting about a third of its staff and moving its headquarters from San Francisco to Washington, D.C. Beset by regulatory troubles around the globe, the company is also pulling back in Europe.
...
https://247wallst.com/consumer-products ... ria-stock/

[slayer74]

Why Juul's European Departure Helps Altria Stock

https://247wallst.com/consumer-products ... ria-stock/

[slayer74]

How New Juul Lawsuits Could Affect Altria Stock?

https://247wallst.com/consumer-products ... 15/altria/

[slayer74]

06/2020
Earnings EPS/Forecast
1.09/1.06
Revenue/Forecast
5.06B/ 5.08B

[slayer74]

Altria Q2 Earnings Are Smoking
Chris Lange
July 28, 2020 11:18 am
Altria Group Inc. (NYSE: MO) reported its most recent quarterly results before the markets opened on Tuesday. The cigarette firm posted $1.09 in earnings per share (EPS) and $5.06 billion in revenue for the second quarter, which compares with consensus estimates that called for $1.06 in EPS and revenue of $5.04 billion. The same period of last year reportedly had EPS of $1.10 on $5.19 billion in revenue.

Management noted that over the first half of 2020, Altria showed resilience considering the volatile market conditions. This was driven largely by solid financial performance in its core tobacco business and steady progress in the noncombustible product portfolio.

Another recent highlight for Altria was that the FDA authorized its IQOS (I Quit Ordinary Smoking) to be marketed as Modified Risk Tobacco Products with a “reduced exposure claim.”

During the quarter, revenues decreased 2.5% year over year due to lower net revenues in the smokeable products segment.

Smokeable Products net revenues decreased 4.3% to $4.34 billion, driven by lower shipment volume and partially offset by higher pricing and lower promotional investments.

Oral Tobacco Products net revenue increased 9.8% to $626 million, driven by higher pricing and higher shipment volume.

In March, Altria borrowed the full $3 billion available under its revolving credit agreement due to the uncertainty arising from the COVID-19 pandemic. The firm also issued long-term senior unsecured notes of $2 billion in May. On the books, Altria ended the quarter with $4.8 billion in cash and cash equivalents.

Looking forward, the company re-established its 2020 full-year earnings guidance based on a better understanding of the pandemic. Currently, Altria expects to see EPS in the range of $4.21 to $4.38. Consensus estimates call for $4.28 in EPS and $20.45 billion in revenue for the full year.

Altria stock traded up about 2% on Tuesday to $43.01, in a 52-week range of $30.95 to $52.45. The consensus price target is $48.57.

https://247wallst.com/consumer-products ... all+St.%29

Altria Group Reports Lower Revenue in the Second Quarter, Declares Dividend Raise

Altria Group (NYSE:MO), owner of Philip Morris USA and other brands, reported some positive signs in its second-quarter earnings released on Tuesday. Revenue declined 3.8%, but adjusted earnings increased year over year.

The decline was mostly due to smokable products, but the Ste. Michelle wine brand suffered because of lower direct-to-consumer sales as well as restaurant closures.

Altria drew down its full $3 billion revolving credit in March and paid it back in full by the end of June. While it now has that credit available, it ended the quarter with $4.8 billion in cash and has an estimated $3 billion after taxes and dividends.

A productive quarter
The company is executing on a 10-year plan to move toward noncombustible smoking products and made several strides during the quarter getting products approved by the Federal Drug Administration (FDA). IQOS and HeatSticks, heated tobacco products that are considered smoke-free alternatives to traditional cigarettes, were approved to be marketed as modified-risk products, which means the company can claim they present a lower risk of tobacco-related disease than other tobacco products. Altria has forged important partnerships to increase distribution of these products in several markets.

It also has several on! products under review at the FDA. on! nicotine patches are made in partnership with Swiss company Helix Innovations. Helix expects a 43% increase in the amount of stores that sell its products.

The company presented an outlook of $4.21 to $4.38 adjusted EPS for the full year -- projected growth between 0% and 4%.

Altria also announced it was raising its dividend from $0.84 to $0.86 per share.

https://www.fool.com/investing/2020/07/ ... ter-d.aspx

[slayer74]

Altria vs Philip Morris: Which Stock Is A More Compelling Buy?
...
Altria (MO)

Altria, which owns the popular Marlbaro brand in US, has been struggling due to its strategic investments in cannabis company Cronos Group and e-cigarette company Juul. Altria recorded impairment charges related to holdings in both the companies in the recent quarters, including a $4.1 billion charge in 2019’s fourth quarter.

Juul was under fire from the FDA (Food and Drug Administration) and other regulators as well as several US states following vaping-related illnesses and deaths.


Altri’s second-quarter revenue declined 3.8% to $6.37 billion due to lower sales of smokable products and the impact of restaurant and bar closures during lockdowns on its wine business. Despite a fall in revenue, adjusted EPS grew 0.9% to $1.09.

Altria showed resilience in volatile conditions which reflects in the 3.9% revenue growth and an 8.5% rise in adjusted EPS in the first half of this year. Following the second-quarter results, it re-established its adjusted 2020 EPS growth guidance in the 0% to 4% range based on more clarity on the adult tobacco purchase trends and an additional quarter of earnings contributions from Anheuser-Busch InBev.

The company is now looking for expansion in the IQOS market after the US FDA authorized IQOS and HeatSticks to be marketed as Modified Risk Tobacco Products with a “reduced exposure” claim. IQOS is a “heat not burn” device considered as an alternative to conventional cigarettes.

It also has an exclusive agreement with Philip Morris International to sell IQOS in the US- and is eyeing growth in the non-combustible space with Helix Innovation’s on! products, which are currently under review by the FDA.

Several companies have suspended dividends due to the impact of the pandemic on their businesses. However, Altria increased its quarterly dividend by 2.4% to $0.86, marking its 55th dividend increase in the past 51 years.

Following the recent results, Merrill Lynch analyst Lisa Lewandowski reaffirmed a Buy rating for Altria stock with a price target of $50. Lisa Lewandowski stated, “MO offers earnings stability, an attractive yield and a valuation near historical lows.” (See Altria stock analysis on TipRanks)

Based on 6 Buys and 5 Holds, Altria stock has a cautiously optimistic Moderate Buy rating. An average price target of $48.80 implies an upside potential of about 13.6% over the next 12-months.

Philip Morris International (PM)

Philip Morris believes that cigarette sales could end in many countries in the next 10 to 15 years as consumers look for safer alternatives. The company has been focusing on capturing the demand for heated tobacco products and its IQOS tobacco heating device.

As per the company, there were 15.4 million IQOS users as the end of the second quarter, up from 14.6 million a year back. It is also seeing strong momentum for IQOS in Japan, the EU region, and Russia.

Currently, the company’s RRPs or reduced-risk products account for about 25% of its revenue. Philip Morris is targeting 90 billion to 100 billion shipments of heated tobacco units by 2021. The recent authorization of IQOS as a modified risk tobacco product by the US FDA is a very favorable development for the tobacco giant.

Philip Morris’ second-quarter revenue declined 13.6% year-over-year to $6.65 billion as higher volumes of heated tobacco units were partially offset by a decline in cigarette shipments. Adjusted EPS of $1.29 reflected an 11.6% fall. Overall, revenue declined 4.5% and adjusted EPS was down 2.0% in the first half of 2020. Philip Morris foresees its 2020 EPS growth (excluding currency impacts) in the 2% to 5% range.

After the recent results, Stifel analyst Christopher Growe maintained a Buy rating for Philip Morris stock while raising the price target to $90 from $85. Growe also upped his 2020 and 2021 estimates backed by “stronger IQOS growth, robust cost savings, and more efficient IQOS spending alongside a continued recovery in volume.” (See Philip Morris stock analysis on TipRanks)

The Street has a Moderate Buy consensus rating for Philip Morris stock with 5 Buys and 2 Holds. An average price target of $85.57 indicates an upside of 7.38% over the next year.

Altria stock has declined 14% year-to-date while Philip Morris was down 6.5% as of August 13. Currently, Altria has a higher dividend yield of 8.0% compared to 6.0% for Philip Morris. Headwinds like regulatory pressure, decline in cigarette volumes, and the impact of travel restrictions due to COVID-19 on duty-free sales continue to concern both Altria and Philip Morris.

However, considering the potential upside over the next 12-months and the higher dividend yield, Altria looks to be a better buy.

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

https://www.tipranks.com/news/altria-vs ... lling-buy/

[slayer74]

Juul to drastically cut workforce, explore exiting some markets

(Reuters) - Juul Labs Inc said on Thursday it would make a "significant" cut to its global workforce and explore pulling out of some European and Asia-Pacific markets to save cash and weather a tumultuous period for the e-cigarette industry.

The company, partly owned by Marlboro maker Altria Group (NYSE:MO) Inc, is planning to lay off about 1,200 employees, more than half its workforce, the Wall Street Journal reported, citing people familiar with the matter. (https://on.wsj.com/3jNvsir)

"No final decisions have been made and we will continue to go through our evaluation process," a Juul spokesman said.

E-cigarette sales have slowed in the United States, Juul's home market, as increased regulatory scrutiny following a rise in teenage vaping and a ban on the sale of popular flavors have hit demand.

"It has seemingly become even easier to sell combustible cigarettes than vapor products," Juul said in a blog post. (https://

Altria's 35% stake in Juul, valued at $12.8 billion in December 2018, dwindled to about $4.2 billion at the end of last year.

Juul said some European and Asia Pacific markets had not provided enough return to justify additional investments. The company pulled out of South Korea this year after it failed to gain traction amid government health warnings.

Juul to drastically cut workforce, explore exiting some markets

https://www.investing.com/news/stock-ma ... ts-2285956

[slayer74]

Altria re-affirms FY20 guidance
Sep. 9, 2020 8:47 AM ET|About: Altria Group, Inc. (MO)|By: Gaurav Batavia, SA News Editor
Altria (NYSE:MO) re-affirms its FY20 guidance adjusted EPS of $4.21 - $4.38 vs. consensus of $4.31 consensus

https://seekingalpha.com/news/3612460-a ... m=referral

[slayer74]

ALTRIA [MO] Earnings
Latest Release
Oct 30, 2020

EPS / Forecast
1.19 / 1.16

Revenue / Forecast
5.68B / 5.52B